Alkylation-induced frameshift mutagenesis during in vitro DNA synthesis by DNA polymerases α and β

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 422, Issue 2, 1998, Pages 255-269

  Eckert, Kristin A ^a   Hile, Suzanne E ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Alkylating agent; Frameshift mutation; Herpes simplex virus thymidine kinase; Polymerase alpha; Polymerase beta; Repetitive DNA

Indexed keywords

ALKYLATING AGENT; DNA POLYMERASE; ETHYLNITROSOUREA; REPETITIVE DNA; THYMIDINE KINASE;

ALKYLATION; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA SEQUENCE; DNA SYNTHESIS; DNA TEMPLATE; FRAMESHIFT MUTATION; IN VITRO STUDY; MUTAGENESIS; MUTATION RATE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL;

ALKYLATING AGENTS; BASE PAIRING; BASE SEQUENCE; DNA; DNA DAMAGE; DNA POLYMERASE BETA; DNA POLYMERASE I; ETHYLNITROSOUREA; FRAMESHIFT MUTATION; MOLECULAR SEQUENCE DATA; MUTAGENESIS; SIMPLEXVIRUS; SUBSTRATE SPECIFICITY; TEMPLATES, GENETIC; THYMIDINE KINASE;

HERPES; SIMPLEXVIRUS;

EID: 0032480954     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00206-1     Document Type: Article

References (49)

1. Yuspa S.H., Poirer M.C. Chemical carcinogenesis: from animal models to molecular models in one decade. Adv. Cancer Res. 50:1991;25-70.
2. Glickman B.W. Study of mutational specificity in the lacI gene of Escherichia coli as a window on the mechanisms of mutation. Environmental and Molecular Mutagenesis. 16:1990;48-54.
3. Miller J.H. Mutational specificity in bacteria. Annu. Rev. Genet. 17:1983;215-238.
4. Singer B., Essigmann J.M. Site-specific mutagenesis: retrospective and prospective. Carcinogenesis. 12:1991;949-955.
5. Loechler E. The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: perspective, prospects and problems. Carcinogenesis. 17:1996;895-902.
6. Eckert K.A., Hile S.E., Vargo P.L. Development and use of an in vitro HSV-tk forward mutation assay to study eukayotic DNA polymerase processing of DNA alkyl lesions. Nucleic Acids Res. 25:1997;1450-1457.
7. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clue to cancer etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878.
8. Greenblatt M.S., Grollman A.P., Harris C.C. Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model. Cancer Res. 56:1996;2130-2136.
9. Singer B. N-Nitroso alkylating agents: formation and persistence of alkyl derivatives in mammalian nucleic acids as contributing factors in carcinogenesis. J. Natl. Cancer Inst. 62:1979;1329-1339.
10. B. Singer, D. Grunberger, Molecular Biology of Mutagens and Carcinogens, Plenum, New York, 1983.
11. Preston B., Singer B., Loeb L.A. Mutagenic potential of O4-methylthymine in vivo determined by an enzymatic approach to site-specific mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 83:1986;8501-8505.
12. Loechler E., Green C., Essigmann J. In vivo mutagenesis by O6-methylguanine built into a unique site in a viral genome. Proc. Natl. Acad. Sci. U.S.A. 81:1984;6271-6275.
13. Lee G.S.-F., Blonsky K.S., On D.L.V., Savage E.A., Morgan A.R., Borstel R.C.v. Base alterations in yeast induced by alkylating agents with differing swain-scott substrate constants. J. Mol. Biol. 223:1992;617-626.
14. Pastink A., Vreeken C., Nivard M.J.M., Searles L.L., Vogel E.W. Sequence analysis of N-ethyl-N-nitrosourea-induced vermilion mutations in Drosphila melanogaster. Genetics. 123:1989;123-129.
15. Jansen J.G., Mohn G.R., Vreiling H., Teijlingen C.M.M.v., Lohman P.H.M., Zeeland A.A.v. Molecular analysis of hprt gene mutations in skin fibroblasts of rats exposed in vivo to N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea. Cancer Res. 54:1994;2478-2485.
16. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Sorge J.A., Putman D.L., Short J.M. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7958-7962.
17. Skopek T.R., Walker V.E., Cochrane J.E., Craft T.R., Cariello N.F. Mutational spectrum at the Hprt locus in spleenic T cells of B6C3F1 mice exposed to N-ethyl-N-nitrosourea. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7866-7870.
18. Harbach, Filipunas, Wang C.S., Aaron DNA sequence analysis of spontaneous and N-ethyl-N-nitrosourea-induced hprt mutations arising in vivo in cytomologus monkey T-lymphocytes. Environmental and Molecular Mutagenesis. 20:1992;96-105.
19. Bronstein S.M., Cochrane J.E., Craft T.R., Swenberg J.A., Skopek T.R. Toxicity, mutagenicity and mutational spectra of N-ethyl-N-nitrosourea in human cell lines with different DNA repair phenotypes. Cancer Res. 51:1991;5188-5197.
20. Eckert K.A., Ingle C.A., Klinedinst D.K., Drinkwater N.R. Molecular analysis of mutations induced in human cells by N-ethyl-N-nitrosourea. Mol. Carcinog. 1:1988;50-56.
21. Singer B., Spengler S., Bodell W.J. Tissue dependent enzyme-mediated repair or removal of O-ethyl pyrimidines and ethyl purines in carcinogen-treated rats. Carcinogenesis. 2:1981;1069-1073.
22. Hashim M.F., Schnetz-Boutaud N., Marnett L.J. Replication of template-primers containing propanodeoxyguanosine by DNA polymerase β J. Biol. Chem. 272:1997;20205-20212.
23. Feig D.I., Loeb L.A. Oxygen radical induced mutagenesis is DNA polymerase specific. J. Mol. Biol. 235:1994;33-41.
24. Akagi T., Hiromatsu K., Iyehara-Ogawa H., Kimura H., Kato T. Specificity of mutations induced by N-methyl-N-nitrosourea in a cDNA of the HPRT gene. Carcinogenesis. 14:1993;725-729.
25. Chaudhuri I.J.M.E. 3-Methyladenine mutagenesis under conditions of SOS induction in Escherichia coli. Carcinogenesis. 12:1991;2283-2289.
26. Roldan-Arjona T., Luque-Romero F.L., Ariza R.R., Jurado J., Pueyo C. Influence of DNA repair by ada and ogt alkyltransferases on the mutational specificity of alkylating agents. Mol. Carcinog. 9:1994;200-209.
27. Thibodeau S.N., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 260:1993;816.
28. Bhanot O.S., Grevatt P.C., Donahue J.M., Gabrielides C.N., Solomon J.J. Incorporation of dA opposite N3-ethylthymine terminates in vitro DNA synthesis. Biochemistry. 29:1990;10357-10364.
29. 2-ethylthymidine in transversion mutagenesis by ethylating agents. Nucleic Acids Res. 20:1992;587-594.
30. Larson K., Sahm J., Shenkar R., Strauss B. Methylation-induced blocks to in vitro DNA replication. Mutat. Res. 150:1985;77-84.
31. Saffhill R., Margison G., O'Connor P. Mechanisms of carcinogenesis induced by alkylating agents. Biochim. Biophys. Acta. 823:1985;111-145.
32. Eckert K.A., Drinkwater N.R. recA-Dependent and recA-independent N-ethyl-N-nitrosourea mutagenesis at a plasmid-encoded herpes simplex virus thymidine kinase gene in Escherichia coli. Mutat. Res. 178:1987;1-10.
33. Pelletier H., Sawaya M.R., Wolfle W., Kraut J. Crystal structure of human DNA polymerase β complexed with DNA: implications for catalytic mechanism, processivity and fidelity. Biochemistry. 35:1996;12742-12761.
34. Miller P.S., Chandrasegaran S., Dow D.L., Pulford S.M., Kan L.S. Synthesis and template properties of an ethylphosphotriester modified decadeoxyribonucleotide. Biochemistry. 21:1982;5468-5474.
35. Beranek D.T. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res. 231:1990;11-30.
36. 4-ethylthymine preferentially form alkyl T·G pairs that do not block in vitro replication in a defined sequence. Carcinogenesis. 14:1993;1915-1919.
37. Shibutani S., Suzuki N., Matsumoto Y., Grollman A.P. Miscoding properties of 3,N4-etheno-2′-deoxycytidine in reactions catalyzed by mammalian DNA polymerases. Biochemistry. 35:1996;14992-14998.
38. Chary P., Lloyd R.S. In vitro replication by prokaryotic and eukaryotic polymerases on DNA templates containing site-specific and stereospecific benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide adducts. Nucleic Acids Res. 23:1995;1398-1405.
39. Efrati E., Tocco G., Eritja R., Wilson S., Goodman M. Abasic translesion synthesis by DNA polymerase β violates the 'A-rule'. J. Biol. Chem. 272:1997;2559-2569.
40. Shibutani S., Grollman A. On the mechanism of frameshift (deletion) mutagenesis in vitro. J. Biol. Chem. 268:1993;11703-11710.
41. K.A. Eckert, P.L. Opresko, DNA polymerase mutagenic bypass and proofreading of endogenous DNA lesions, Mutat. Res., in press (1998).
42. Podlutsky A., Osterholm A.-M., Hou S.-M., Hofmaier A., Lambert B. Spectrum of point muations in the coding region of the hypoxanthine-guanine phosphoribosyltransferase (hprt) gene in human T-lymphocytes. Carcinogenesis. 19:1998;557-566.
43. Thomas D.C., Roberts J.D., Sabatino R.D., Myers T.W., Tan C.-K., Downey K.M., So A.G., Bambara R.A., Kunkel T.A. Fidelity of mammalian DNA replication and replicative DNA polymerases. Biochemistry. 30:1991;11751-11759.
44. Sia E.A., Jinks-Robertson S., Petes T.D. Genetic control of micrsatellite stability. Mutat. Res. 383:1997;61-70.
45. Duckett D.R., Drummond J.T., Murchie A.I.H., Reardon J.T., Sancar A., Lilley D.M.J., Modrich P. Human MutSα recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6443-6447.
46. Huang H.et al. APC Mutations in colorectal tumors with mismatch repair deficiency. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9049-9054.
47. Richards B., Zhang H., Phear G., Meuth M. Conditional mutator phenotype in hMSH2-deficient tumor cell lines. Science. 277:1997;1523-1526.
48. Bhattacharyya N.P., Skandalis A., Ganesh A., Groden J., Meuth M. Mutator phenotype in human colorectal carcinoma cell lines. Proc. Natl. Acad. Sci. U.S.A. 91:1994;6319-6323.
49. Kat A., Thilly W.G., Fang W., Longley M.J., Li G., Modrich P. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6424-6428.